CASP1 and pneumococcal meningitis: Conversely, treatment of caspase-1-deficient mice with LPS injection resulted in survival advantage compared to WT mice [202], and an improved clinical status was was observed in caspase-1-deficient mice with Pneumococcal meningitis and Pseudomonas aeruginosa corneal infection [211, 212].